NClip

Medication Administration Documentation and Reassessment

4 min read

Medication Administration Documentation and Reassessment

Key Points

  • Documentation after medication administration verifies right documentation and right response.
  • Charting must be timely, accurate, and use approved terminology/abbreviations only.
  • Medication documentation is part of the legal medical record and must be complete, reliable, and defensible.
  • PRN medication effects require reassessment based on route-specific onset windows.
  • For IV push administration, include route/rate, flush solution details, IV site location, and related pre/post assessment findings.
  • IV push charting should capture both indication and measurable response data (for example urine output, lung sounds, edema trend, pain-score change).
  • MAR/eMAR entries should capture medication, dose, route, time, indication/instructions, and clinically relevant response data.
  • For enteral tube medication administration, chart flush volumes in I&O, route-specific tube details, and feed/suction hold-resume actions per policy.
  • eMAR alerts/prompts add safety layers but do not replace independent nursing clinical judgment.
  • Time documentation should use four-digit military notation (24-hour clock) to prevent AM/PM conversion errors.

Equipment

  • MAR and patient medical record access
  • eMAR access and downtime paper-MAR workflow per facility policy
  • Approved abbreviation/reference guide per facility policy
  • Post-medication assessment tools (pain scale, reaction check, vital signs)
  • Provider-notification workflow for adverse events

Procedure Steps

  1. Document medication administration immediately after the dose is given.
  2. Do not chart medication administration before the medication is actually administered.
  3. Record essential details: medication name, dose, route, four-digit military time (24-hour clock), administration site when applicable, and ordered/administration attribution fields required by the chart.
  4. During eMAR downtime or paper-MAR use, transcribe each active order accurately (medication, dose, route, frequency, prescriber, order date/time, and scheduled administration times) using the facility MAR template.
  5. For paper MAR administration entries, initial the exact date/time box and ensure initials can be linked to printed name/signature in the MAR identifier section.
  6. Use approved abbreviations only and avoid unsafe symbols or ambiguous shorthand.
  7. For PRN medications, chart indication, effectiveness, and any reaction findings.
  8. For IV push workflows, document administration rate, flush solution type/volume/rate, and IV site location/patency findings linked to the dose event.
  9. For enteral-tube medication workflows, document tube route, pre-/between-/post-med flush volumes, feeding or suction hold/resume timing, and total flush volume on intake/output records per policy.
  10. Review eMAR prompts/alerts (for example allergy, contraindication, discontinued order, or too-soon administration warning) and reconcile them with bedside assessment before final sign-off.
  11. Perform post-administration reassessment according to route/onset guidance.
  12. For oral medications, reassess response commonly within about 30 to 60 minutes unless medication-specific policy indicates otherwise.
  13. For IV medications, reassess response sooner (commonly about 5 to 15 minutes) according to medication onset and policy.
  14. For pain workflows, common reassessment targets are about 30 to 60 minutes after oral analgesics and about 10 to 15 minutes after IV analgesics.
  15. Document objective response findings and patient-reported outcomes.
  16. For respiratory medications, explicitly compare pre/post respiratory findings (respiratory rate, SpO2, lung sounds, work of breathing, and dyspnea trend) and escalate promptly if symptoms fail to improve or worsen.
  17. If a dose is missed or refused on paper MAR, follow facility notation standards and record the reason plus follow-up assessment timing in the designated narrative area.
  18. If adverse reaction occurs, document event details in MAR plus required progress note content, provider notification, and follow-up orders.
  19. Mark non-administration dates clearly for pre-order or post-discontinuation periods, and annotate order changes/discontinuation with date and initials per facility MAR convention.
  20. Correct documentation errors as soon as identified: use the electronic edit function for eMAR entries and follow paper-chart correction rules when on downtime forms.
  21. On paper MAR corrections, draw a single line through the error and add date/initials; do not erase, use correction fluid, or obscure the original entry with multiple strike lines.
  22. Include narrative response details that allow clinical trend comparison during handoff and reassessment.
  23. Confirm that charting supports continuity, safety, and legal record standards.

Common Errors

  • Delayed charting → omission, duplicate-dose, and continuity risk.
  • Using unapproved symbols/abbreviations → misinterpretation and medication error risk.
  • Missing PRN indication and reassessment → inability to evaluate treatment effectiveness.
  • Missing IV push rate/flush details or site-specific findings → incomplete dose-accountability and troubleshooting trail.
  • Missing enteral flush I&O totals or feed/suction hold-resume charting → incomplete medication-delivery traceability.
  • Incomplete adverse-event documentation → delayed escalation and legal vulnerability.
  • Missing paper-MAR notation for missed/refused doses → unclear accountability and handoff gaps.
  • Ignoring eMAR alerts or overrelying on prompts without bedside judgment → preventable administration/documentation harm.
  • Repeated chart corrections from distraction-prone workflow → rising risk for secondary documentation errors.

Graph View